Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2014
05/01/2014US20140120629 Nucleic acid structure complex including nucleic acids, raman-active molecules, and metal particles, method of preparing the same, and method of detecting target material by using the nucleic acid structure complex
05/01/2014US20140120628 Near-infrared fluorescent dyes with large stokes shifts
05/01/2014US20140120627 Method for labeling nanoclay for tracking them within different solid and liquid material
05/01/2014US20140120626 Method of marking hydrocarbon liquids
05/01/2014US20140120614 Antibodies against clostridium difficile toxins and uses thereof
05/01/2014US20140120603 High sensitivty medical device and manufacturing thereof
05/01/2014US20140120574 Fluorescent nitric oxide probes and associated methods
05/01/2014US20140120573 Engineering individually addressable cellular spheroids using aqueous two-phase systems
05/01/2014US20140120572 Method for determining a plasma volume variation and devices for implementing the method
05/01/2014US20140120570 Devices and methods for manipulating components in a fluid sample
05/01/2014US20140120569 Sebocytes, sebocyte cell lines and applications thereof
05/01/2014US20140120568 System and methodology for analyzing low-density lipoprotein transport within a multi-layered arterial wall
05/01/2014US20140120567 Compounds and Method of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators
05/01/2014US20140120562 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
05/01/2014US20140120561 Antibody specifically binding to insulin-like growth factor-1
05/01/2014US20140120559 Diabetes panel
05/01/2014US20140120558 Detecting Cells Secreting A Protein Of Interest
05/01/2014US20140120557 Photocrosslinkable Peptide-MHC Complexes for Antigen-Specific T Cells and Methods of Using the Same
05/01/2014US20140120554 Anti ceacam1 antibodies and methods of using same
05/01/2014US20140120553 T2r, a novel family of taste receptors
05/01/2014US20140120552 Sensitive And Rapid Methods Of Using Chimeric Receptors To Identify Autoimmune Disease And Assess Disease Severity
05/01/2014US20140120551 Methods of diagnosing, predicting and treating cardiovascular disease
05/01/2014US20140120550 Cell analysis by mass cytometry
05/01/2014US20140120549 High sensitivity quantitation of peptides by mass spectrometry
05/01/2014US20140120543 Expression of isoform 202 of ercc1 for predicting response to cancer chemotherapy
05/01/2014US20140120538 Coelenterazine analogues and coelenteramide analogues
05/01/2014US20140120537 Collection and Concentration System for Biologic Substance of Interest and Use Thereof
05/01/2014US20140120532 Method of sequential and multiple immunostaining for detection of various antigens in the same specimens
05/01/2014US20140120530 Method for classifying/counting leukocytes, reagent kit for classifying leukocytes, and reagent for classifying leukocytes
05/01/2014US20140120528 Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome
05/01/2014US20140120525 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
05/01/2014US20140120521 Microfluidic device, microfluidic system and method for controlling microfluidic test device
05/01/2014US20140120238 Formulations and methods to provide nutrition to human and other patients
05/01/2014US20140120206 Systems and methods to estimate nutritional needs of human and other patients
05/01/2014US20140120174 Methods of prognosis and diagnosis of sepsis
05/01/2014US20140120167 Multifunctional chemo- and mechanical therapeutics
05/01/2014US20140120156 Compositions and methods for exosome targeted expression
05/01/2014US20140120128 Use of yscf, truncated yscf and yscf homologs as adjuvants
05/01/2014US20140120126 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
05/01/2014US20140120122 Method for monitoring vaccine response using single cell network profiling
05/01/2014US20140120117 Treatment of tumors using specific anti-l1 antibody
05/01/2014US20140120112 Therapeutics for age-related macular degeneration
05/01/2014US20140120107 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/01/2014US20140120102 Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
05/01/2014US20140120089 Antibodies to insulin-like growth factor i receptor
05/01/2014US20140120037 Method for detection of amyloids beta oligomers in a fluid sample and uses thereof
05/01/2014US20140119996 Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs
05/01/2014US20140119995 Device for detecting an analyte
05/01/2014US20140119994 Sample analyzer
05/01/2014US20140116353 Fuidi herd management and risk stratification methods
05/01/2014US20140116352 Fuidi herd management and risk stratification methods
05/01/2014US20140116150 Methods for Determining Reactive Index for Cementitious Components, Associated Compositions, and Methods of Use
05/01/2014US20140116119 Device and Method for Measuring a Quantity of Water in Oil or Oil Products
05/01/2014US20140116118 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
04/2014
04/30/2014EP2725360A1 Biomarkers for the prognosis of ischemic stroke
04/30/2014EP2725359A1 Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
04/30/2014EP2725358A1 Release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
04/30/2014EP2725357A2 Probe for ifret and usage of same
04/30/2014EP2725356A2 Microscope apparatus for detecting or imaging protein using ifret probe, and method for detecting or imaging protein using same
04/30/2014EP2725355A1 Method and device for measurement of the heating value of a gas stream
04/30/2014EP2725354A1 Post-combustion determination of the water content of a solid fuel
04/30/2014EP2725350A2 Method for gas detection and corresponding gas sensor device
04/30/2014EP2725346A1 Light measurement device, light measurement method, and light measurement program
04/30/2014EP2725345A1 Light measurement device, light measurement method, and light measurement program
04/30/2014EP2725340A2 Permeameter for in-situ measurement of saturated hydraulic conductivity
04/30/2014EP2725094A1 Epithelial tissue model
04/30/2014EP2724163A2 Microfluidic devices and methods for separating and detecting constituents in a fluid sample
04/30/2014EP2724162A2 Diagnostic method
04/30/2014EP2724161A1 A method for the identification of beta-sheet aggregated protein ligands
04/30/2014EP2724160A2 Acoustic cytometry methods and protocols
04/30/2014EP2724159A1 Competitive s100a9 immunoassays
04/30/2014EP2724158A1 Monitoring protein trafficking using beta-galactosidase reporter fragment complementation
04/30/2014EP2724157A1 Method for screening cells
04/30/2014EP2724156A1 Methods and compositions for treatment of cancer and autoimmune disease
04/30/2014EP2724155A2 Methods for identifying candidate compounds for treating and/or limiting development of diabetes
04/30/2014EP2724154A1 Methods and compositions for detecting gastrointestinal and other cancers
04/30/2014EP2724153A1 High-precision determination of the mass proportion of a component in a multi-component fluid
04/30/2014EP2724149A1 Matric potential sensor and related methods
04/30/2014EP2723905A1 Signatures and determinants associated with prostate cancer progression and methods of use thereof
04/30/2014EP2723899A2 Diagnostic methods for eosinophilic esophagitis
04/30/2014EP2723898A1 Methods and compositions for the treatment and diagnosis of bladder cancer
04/30/2014EP2723888A1 Risk assessment for phenytoin-induced adverse drug reactions
04/30/2014EP2723886A1 Determination of direct thrombin inhibitors in fluids like serum or urine
04/30/2014EP2723866A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
04/30/2014EP2723853A1 In vitro cardiovascular model
04/30/2014EP2723769A2 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
04/30/2014EP2723768A2 Diagnosis and/or prognosis of parkinson's disease dementia
04/30/2014EP2723765A2 Molecules specifically binding pancreatic beta cells biomarkers
04/30/2014EP2723753A1 Selective glycosidase inhibitors and uses thereof
04/30/2014EP2723677A1 Method of operating a catalytic steam-hydrocarbon reformer
04/30/2014EP2723384A1 Treatment of proteinopathies
04/30/2014EP2723382A1 Methods and compositions for modulating voltage-gated calcium channel function
04/30/2014EP2723365A1 Compositions and methods for the therapy and diagnosis of cancer
04/30/2014EP2723361A1 Methods of treating chronic disorders with complement inhibitors
04/30/2014EP2723235A1 Test unit cartridge for analyte testing device
04/30/2014DE112012003244T5 Urin-Komponentenanalysevorrichtung und Urin-Komponentenanalyseverfahren Urine component analysis device and urine component analysis method
04/30/2014DE112011105263T5 Verfahren zur quantitativen Messung der mechanischen Stabilitätszeit (MST) von Latex-Suspensionen und Vorrichtung zur Verwendung bei dem Verfahren A method for quantitative measurement of the mechanical stability time (MST) of latex suspensions and apparatus for use in the method
04/30/2014DE102013208679A1 Messsonde zur Messung in Metall- oder Schlackeschmelzen Probe for measurements in metal or slag melts
04/30/2014DE102012219866A1 Microfluidic module for analyzing three-dimensional structures, comprises a module body, a channel for a hydrodynamic positioning of structure at constriction, and flow-moderate electrodes for enabling impedimetric measurements of structure
04/30/2014DE102012219656A1 System zur durchführung einer berührungslosen messung an einer probe und probenträger System for the enforcement of non-contact measurement on a sample and sample carrier
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 3937